Jaguar Health Inc. (NASDAQ: JAGX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT JAGUAR HEALTH INC.

Jaguar Health Inc. (NASDAQ: JAGX)
Listen to this Section


$0.85
-0.0450 ( -2.96% ) 76.1K

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Market Data


Open $0.85
Previous Close $0.90
Volume 76.1K
Market Cap $10.03M
Day Range $0.84 - $0.89
52 Week Range $0.78 - $21.60
Shares Outstanding 11.80M
Change % -2.96%
Net Change ▼ -0.0450
Insider Ownership -0.01%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2015
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,307,689.00

Date Type Amount Purchased Purchaser
2024-05-21 Sale -871.00 Chaturvedi Pravin R
2024-05-21 Sale -871.00 Wolin Jonathan S.
2024-05-21 Sale -612.00 King Steven R.
2024-05-21 Sale -431.00 Lizak Carol R.
2024-05-21 Sale -2695.00 CONTE LISA A
2024-04-17 Sale -600.00 CONTE LISA A
2024-04-17 Sale -60.00 Lizak Carol R.
2024-04-17 Sale -134.00 Chaturvedi Pravin R
2024-04-17 Sale -89.00 Wolin Jonathan S.
2024-04-17 Sale -178.00 King Steven R.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Jul 16, 2024
8-k 8K-related 15 Jun 26, 2024
8-k 8K-related 15 Jun 21, 2024
sc Insider transactions 1 Jun 10, 2024
8-k 8K-related 13 Jun 10, 2024
defa14a Other 2 May 31, 2024
ars Annual reports 1 May 28, 2024
8-k 8K-related 19 May 23, 2024
424b5 Other 2 May 23, 2024
4 Insider transactions 1 May 21, 2024

Latest News


× Before browsing our site, please accept our cookies policy